Brain-computer interfaces in non-medical applications pose ethical and privacy concerns

What's this about?

People disagree about whether brain-computer links, or BCIs, create unfair risks outside hospitals.

These tools read brain signals, so people ask who controls the data and whether users can say no.

What supporters say

• Brain data may reveal focus, likes, feelings, identity, or other private brain facts.
• BCIs may face special hacking risks, including attacks that trick systems or change how they work.
• BCI use may pressure people, limit free choice, or treat some groups unfairly.
• Some companies may collect, share, or keep brain data without giving users enough control.

What critics say

• Many consumer BCIs can only guess simple things, so they cannot read thoughts like a book.
• Possible risks do not prove that these tools now cause widespread harm.

How to read this

The number of points on each side does not show who is right; the stronger proof matters more.

The bottom line

BCIs are not automatically harmful, but they raise serious privacy, safety, fairness, and choice concerns.

The concerns deserve strong rules, even though we are not sure yet about widespread harm today.

Non-medical brain-computer interfaces (BCIs) are not automatically harmful, but they raise serious questions about privacy, security, consent and fairness. The key issue is how much these systems can infer, who controls the data, and whether people can freely refuse their use.

The case for

Neural data can be unusually intimate. Reviews of BCIs and related consumer devices say brain signals may help infer attention, preferences, emotional states, identity or other mental characteristics. That makes them potentially more sensitive than many ordinary kinds of behavioral data. Surveys also show that people in the United States generally view brain data as highly private, strengthening the case for meaningful consent and user control rather than treating it like routine app data (see Figure 3).1

Privacy concerns are not limited to hypothetical “mind-reading.” An assessment of 30 consumer neurotechnology companies found major differences in how firms describe the collection, sharing, retention and deletion of brain data, as well as the control given to users. Legal and ethics reviews identify related concerns over ownership, consent, discrimination, autonomy, security and gaps in regulation. These findings show that governance problems can arise from ordinary commercial data practices, even before more advanced systems become possible (see Figure 4).2

BCIs also create distinct cybersecurity risks. A proof-of-concept study involving 27 people examined whether subliminal or side-channel attacks could exploit EEG-based BCI interactions. Other research has described weaknesses in machine-learning systems that interpret EEG signals, potentially affecting reliability, safety and trust. A U.S. Government Accountability Office assessment lists cybersecurity alongside privacy, data governance, safety, equity and regulatory uncertainty as major policy challenges (see Figure 2).3

The risks are especially significant when BCIs are used where people have unequal power, such as workplaces, schools or targeted marketing. Ethics and policy reviews warn that neural measures could support coercive monitoring, discrimination based on inferred cognitive traits, unequal access or pressure to use enhancement technologies. A person may technically agree to monitoring without having a genuinely free choice, particularly when employment, education or other opportunities are at stake.4

The case against

The strongest counterargument is that many consumer systems have limited ability to interpret brain activity. Consumer EEG devices are relatively affordable and useful for research, but they can also be noisy, methodologically inconsistent and poorly validated. That limits claims that an ordinary headset can reliably reveal detailed private thoughts. It does not, however, rule out less ambitious inferences or risks involving data retention and secondary use.5

Nor is there strong evidence that current non-medical BCI products have already caused widespread harm. Reviews by the Nuffield Council on Bioethics and the Government Accountability Office indicate that many concerns involve expected future capabilities, weak governance or uncertain adoption, rather than a documented pattern of large-scale injury or abuse. The technical attack study was small, and evidence that a system is vulnerable does not show how often real-world attacks occur or how damaging they would be.

There are also potential benefits. BCIs are being explored for attention-training games, gaming, accessibility and human-computer interaction, although the effectiveness of some consumer applications remains disputed. The risks therefore vary widely: a headset that processes signals locally for recreation presents a different profile from one that uploads, stores or sells data, or uses it to assess workers or students.6

The bottom line

The evidence favors the claim, with high confidence that non-medical BCIs raise genuine ethical and privacy concerns. The supporting case draws on several different kinds of evidence: privacy research, public-attitudes surveys, commercial policy reviews, cybersecurity studies and government assessments. Together, they show that the risks are not merely speculative.

Confidence is lower about the current size and frequency of harm. Existing research does not provide a long-term measure of consumer exposure, misuse or injury, and public company policies do not necessarily show how firms operate in practice. The main uncertainty is how accurately particular devices can infer mental characteristics, what companies do with the data, and how often coercive, discriminatory or security-related harms occur.

The most defensible approach is proportional protection rather than a blanket judgment. Non-medical BCIs should be assessed according to what they measure, where the data go and who can demand access, with safeguards for consent, privacy, security and fair treatment.